Cargando…
Tumor-Free Transplantation of Patient-Derived Induced Pluripotent Stem Cell Progeny for Customized Islet Regeneration
Human induced pluripotent stem cells (iPSCs) and derived progeny provide invaluable regenerative platforms, yet their clinical translation has been compromised by their biosafety concern. Here, we assessed the safety of transplanting patient-derived iPSC-generated pancreatic endoderm/progenitor cell...
Autores principales: | El Khatib, Moustafa M., Ohmine, Seiga, Jacobus, Egon J., Tonne, Jason M., Morsy, Salma G., Holditch, Sara J., Schreiber, Claire A., Uetsuka, Koji, Fusaki, Noemi, Wigle, Dennis A., Terzic, Andre, Kudva, Yogish C., Ikeda, Yasuhiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AlphaMed Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4835241/ https://www.ncbi.nlm.nih.gov/pubmed/26987352 http://dx.doi.org/10.5966/sctm.2015-0017 |
Ejemplares similares
-
Indolactam V/GLP-1-mediated Differentiation of Human iPS Cells into Glucose-Responsive Insulin-Secreting Progeny
por: Thatava, Tayaramma, et al.
Publicado: (2010) -
Pancreatic Stellate Cells Prolong Ex Vivo Islet Viability and Function and Improve Engraftment
por: Paul, Pradyut K, et al.
Publicado: (2022) -
Closure of a Recurrent Bronchopleural Fistula Using a Matrix Seeded With Patient-Derived Mesenchymal Stem Cells
por: Aho, Johnathon M., et al.
Publicado: (2016) -
Reprogrammed keratinocytes from elderly type 2 diabetes patients suppress senescence genes to acquire induced pluripotency
por: Ohmine, Seiga, et al.
Publicado: (2012) -
Targeted Derivation of Organotypic Glucose- and GLP-1-Responsive β Cells Prior to Transplantation into Diabetic Recipients
por: Zhu, Yaxi, et al.
Publicado: (2019)